initiation of replication on a damaged template, which can EH8 9AG, UK result in fixation of mutations, accumulation of double-strand *On behalf of the Scottish Melanoma Group breaks, chromosome instability and cancer (4). During arrest 3 To whom correspondence should be addressed the damage may be repaired by NER and the cycle resumes Email: david.melton@ed.ac.uk or, alternatively, the apoptotic (5) or replicative senescence pathways may be triggered. Xeroderma pigmentosum (XP) is The nucleotide excision repair pathway has evolved to the paradigm for human inherited diseases with DNA repair deal with UV light-induced DNA damage. Individuals with deficiency and cancer predisposition (for a review see ref. 6). the rare inherited nucleotide excision repair deficiency disease xeroderma pigmentosum have a 1000-fold increased
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In this autosomal recessive disease there is an NER deficiency incidence of skin cancer. We are interested in the possibility and a 1000-fold increased risk of skin cancer. that more subtle changes in nucleotide excision repair
Although study of the rare disease XP has identified complete genes, resulting in either a reduced capacity for repair NER deficiency as a dramatic genetic risk factor for skin or in altered interactions between repair proteins and cancer, we are interested in the possibility that more subtle components of the cell cycle control machinery, might changes in NER genes also constitute important risk factors constitute important genetic risk factors for the developfor the development of skin cancer in the general population.
ment of skin cancer in the general population. To investigate
The simplest way that we can envisage this is if the change this hypothesis we have compared the frequency of polyresulted in a slight, but functionally significant, reduction in morphisms in exons 6, 22 and 23 of the XPD gene in repair capacity. In the context of many years skin exposure to melanoma patients and a control group. For each of these UV light and continual challenge to the repair system, even a two allele polymorphisms one of the alleles was overslight reduction in repair capacity could result in a significantly represented in the melanoma group and there was a increased risk of skin cancer. Some studies to compare DNA significant association with melanoma. Importantly, this repair in cancer patients with a control population have reported association did not extend to markers immediately flanking significantly reduced repair capacity in the patient samples. the XPD gene, thus providing evidence that XPD gene
The most relevant to our work involve basal cell carcinoma polymorphisms might predispose to melanoma in the (BCC) (7,8), but reductions in repair have also been reported general population. There is a report that one of the for lung cancer (9) and squamous cell carcinoma of the head and polymorphic XPD alleles (exon 23 Lys), which is overneck (SCCHN) (10). However, the correlation between reduced represented in the melanoma group, has reduced repair repair and cancer is not universal: it was not found in an proficiency and we discuss the possibility that this is independent study of BCC (11) nor in a study of cutaneous the causal change to the XPD gene that predisposes to melanoma (12). The reliability of this type of epidemiological melanoma.
investigation and the difficulties of making comparisons between studies have been discussed in a recent review (13). According to this model XP heterozygotes (carriers), who Introduction will be much more frequent in the population than individuals with XP (~1 in 250 000 for XP,~1 in 300 for carriers) (14) , The nucleotide excision repair (NER) pathway has evolved to would be expected to have reduced NER and a higher incidence deal with UV light-induced DNA damage. In a multi-step of skin cancer. Conventional assays to measure NER have process, involving at least 25 proteins, the helix distorting often been unable to discriminate reliably between carriers lesion is first recognized, the double helix is unwound, a dual and controls (15; and references therein). However, a simple incision is made to release a lesion-bearing oligonucleotide and X-ray-induced chromosome aberration assay in blood lymphorepair synthesis and ligation complete the process (reviewed in cytes, which has been used to show an association between ref. 1). NER does not operate in isolation; it is closely coordinated with other key cellular processes, such as transcripreduced DNA repair and breast cancer (16) , was able to detect tion and DNA replication. Although NER operates over the XP carriers (17). A small excess incidence of skin cancer has been reported in some families of XP patients (18) , but these alterations on cancer predisposition. An ERCC1 polymorphism
Statistical analysis
was associated with adult-onset glioma (22) . Two XRCC1 gene
We first investigated whether the observed genotype distributions at each polymorphisms were associated with SCCHN (23) and one of locus under study were consistent with a Hardy-Weinberg equilibrium. Having confirmed that this was the case, we assumed that alleles were independent these was correlated with increased levels of tobacco-and at each locus and compared allele frequencies among cases and controls.
age-related DNA damage (24) .
These tests were performed using a χ 2 test with Yates correction. This analysis
Returning to NER, the proteins function in a series of was then extended by carrying out a haplotype analysis using the linkage complexes and XPB and XPD also interact with p53 (25 apoptotic response (26) , indicating that these interactions have functional significance. The other aspect of our hypothesis is Results that NER gene polymorphisms might predispose to skin cancer because of altered interactions with the cell cycle control
To carry out an association study of XPD gene polymorphisms and melanoma, blood samples were obtained from machinery rather than through reduced DNA repair activity: a weaker p53-mediated cell cycle arrest response following 28 melanoma patients attending the Dermatology Department at the Royal Infirmary of Edinburgh. The criteria for suitability UV-induced DNA damage to the skin could increase the likelihood of DNA replication proceeding on an unrepaired were chosen to maximize the chance of there being a strong genetic component to the disease. Control blood samples were template, with a resulting increased likelihood of skin cancer.
To test our hypothesis we have carried out a study to also obtained from 33 donors at the Scottish Blood Transfusion Service in the same hospital. The mean age of the patients was compare the frequency of polymorphisms at three different positions in the XPD gene in patients with malignant melanoma 42 Ϯ 10, compared with a mean age of 45 Ϯ 10 for the controls. PCR assays were established for individual XPD exons and and a control group. For each polymorphism we have found a significant association with melanoma which does not extend products were examined for variation by SSCP analysis. Variation was observed for exons 6, 18, 20, 22 and 23 and a to markers flanking the XPD gene. We discuss the evidence that one of these polymorphisms causes a functional change detailed analysis was carried out for exons 6, 22 and 23. For each of these exons SSCP analysis indicated a two allele in the XPD protein that predisposes to melanoma. polymorphism, and this was confirmed by DNA sequencing. Once the single nucleotide changes responsible for the exon Materials and methods 6, 22 and 23 polymorphisms had been identified it became Subjects clear that they had all been reported previously (20) . Using distributions. This confirmed that the observed distributions Blood samples (10 ml whole blood/EDTA) were obtained from controls and
were consistent with a Hardy-Weinberg equilibrium. We theremelanoma subjects. Case and control specimens were handled similarly fore assumed independence of alleles at these exons and and analysed contemporaneously. DNA was isolated using a Qiagen genomiccompared allele counts, rather than genotypes, in melanoma tip 100 and the manufacturer's protocol (Qiagen, UK).
cases and controls because of the resulting increased power P Ͻ 0.005; 12.0 for exon 23/exon 6, P Ͻ 0.001; 6.71 for exon 22/exon 23, P Ͻ 0.025). Thus, we have obtained clear evidence of a statistically significant positive association between three XPD polymorphisms and melanoma. Of course, in addition to an alteration in the XPD protein itself being responsible for the association there are a number of other possible alternative explanations: chance, artefact, linkage disequilibrium and population stratification. These competing explanations are discussed later, but in order to further explore linkage disequilibrium as an explanation for the association we decided to analyse additional markers on either side of the XPD locus. If linkage disequilibrium was responsible for the association observed between XPD and melanoma we hypothesized that a similar association would also occur between the markers flanking XPD and disease status. A detailed map and extensive sequence information is available for human chromosome 19q13.2-q13.3 (28), which contains two other DNA repair genes, the NER gene ERCC1 and the single-strand break repair gene XRCC1, in addition to XPD (ERCC2). A map of a 1 Mb 5Ј to XPD. For CKM RFLPs which had been described in exon 8 and in the 3Ј flanking region (29) were typed. For ERCC1 an RFLP assay was devised for a previously described polymorphism in exon 4 (20) . Details of the ERCC1 and CKM polymorphisms are given in Table II . As before, we first confirmed that the genotype distributions at these loci were consistent with those expected under Hardy-Weinberg equilibrium and then compared allele counts found in melanoma cases and controls (see Table IV ). Contrary to the situation with XPD itself, no evidence of association was found between any of the flanking markers and melanoma. patients attending the Dermatology Department at the Royal Infirmary of Edinburgh. The inclusion criteria for the study were chosen to maximize the chance of a strong genetic This analysis was extended by carrying out a haplotype analysis using the linkage utility program EH (27). This component to their disease. Control samples were taken at random from donations made to the Scottish Blood Transfusion program tests for allelic association between loci by comparing the likelihoods of the data under the assumption of no Service located in the same hospital. The mean ages of the patient (42 Ϯ 10) and control groups (45 Ϯ 10) were equivalent. association and of association. In the former case it is assumed that alleles at different loci occur independently, so haplotype All genotypes analysed in the control group were in HardyWeinberg equilibrium and we consider that it constitutes an frequencies are formed as the product of constituent allele frequencies, while if association is allowed for, haplotype acceptable control group for this exploratory study. In addition, to strengthen the case for the suitability of our control group, frequencies are estimated from the data. The program estimates the haplotype frequencies under the assumption of no allelic the C allele frequencies at the polymorphic sites in exon 6 (0.64) and 23 (0.41) of the XPD gene in our control group association (H 0 ), allelic association between markers but not with disease (H 1 ) and association between alleles and disease were not significantly different from those reported for the control group in a recent Danish study (exon 6, 0.58; exon as well as allelic association (H 2 ). Analysis of allele counts with the linkage utility program EH for the following pairs of 23, 0.38) (30) : for exon 6, χ 2 with Yates correction ϭ 0.68, P ϭ 0.7; for exon 23, χ 2 with Yates correction ϭ 0.06, P ϭ 0.7. exons all confirmed very strong marker-marker association (H 1 χ 2 values of 37.2, 42.1 and 87.1 for exon 22/exon 6, exon
This work was undertaken to test a prior hypothesis based on a plausible biological model to explain a functional link 23/exon 6 and exon 23/exon 22, respectively, all P values Ͻ0.001). It also confirmed significant allele association between the XPD protein and predisposition to melanoma. We consider that chance is an unlikely explanation for the between these three alleles and disease status (H 2 -H 1 χ 2 values with 1 degree of freedom of: 10.5 for exon 22/exon 6, association observed since three separate polymorphisms within the XPD gene all showed the association. In addition, risk associated with the XPD polymorphisms that we have reported is modest, the allele frequency (and hence prevalence while this study was being carried out a similar association, with the same direction of risk, was reported for the same of 'exposure') is high and thus the population attributable risk (the impact on disease incidence in the population if exon 6 and 23 polymorphisms that we have analysed and basal cell carcinoma (30; see below). An artefactual explanation the association is causal) could be high. Furthermore, if the association is confirmed in a larger study and similar for the association, such as the genotypes obtained being affected by problems of storage or analysis, is equally unlikely.
associations are found for other NER genes, then the combination of particular alleles of several different NER genes could Control and case samples were obtained and processed contemporaneously and all the genotypes from the control combine to give a stronger predisposition to skin cancer in the general population. group were in Hardy-Weinberg equilibrium. In addition, as mentioned above, the XPD exon 6 and 23 allele frequencies in our control group agree with a previous report.
flanking markers, has been reported in a Danish study for the (17). However, in a report of the association between XPD 10. Cheng,L., Eicher,S.A., Guo,Z., Hong,W.K., Spitz,M.R. and Wei,Q. (1998) polymorphisms and BCC it was stated that no difference in Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev., 7, 465-468. repair between the Lys and Gln alleles had been found using 11. Hall,J., English,D.R., Artuso,M., Armstrong,B.K. and Winter,M. (1994) host cell reactivation and Comet assays (30) . It is possible that DNA repair capacity as a risk factor for non-melanocytic skin cancer-a the causative change within the XPD gene remains to be molecular epidemiological study. Int. J. Cancer, 58, 179-184.
identified.
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